Familial Adenomatous Polyposis: Experience from a Study of 1164 Unrelated German Polyposis Patients

<p>Abstract</p> <p>The autosomal-dominant precancerous condition familial adenomatous polyposis (FAP) is caused by germline mutations in the tumour suppressor gene <it>APC</it>. Consistent correlations between the site of mutations in the gene and clinical phenotype hav...

Full description

Bibliographic Details
Main Authors: Friedl Waltraut, Aretz Stefan
Format: Article
Language:English
Published: BMC 2005-09-01
Series:Hereditary Cancer in Clinical Practice
Subjects:
Online Access:http://www.hccpjournal.com/content/3/3/95
id doaj-cb5d6340d62d40db8c8bcb6183d6156d
record_format Article
spelling doaj-cb5d6340d62d40db8c8bcb6183d6156d2020-11-25T00:20:55ZengBMCHereditary Cancer in Clinical Practice1897-42872005-09-01339511410.1186/1897-4287-3-3-95Familial Adenomatous Polyposis: Experience from a Study of 1164 Unrelated German Polyposis PatientsFriedl WaltrautAretz Stefan<p>Abstract</p> <p>The autosomal-dominant precancerous condition familial adenomatous polyposis (FAP) is caused by germline mutations in the tumour suppressor gene <it>APC</it>. Consistent correlations between the site of mutations in the gene and clinical phenotype have been published for different patient groups. We report our experiences of <it>APC </it>mutation analysis and genotype-phenotype correlations in 1166 unrelated polyposis families and discuss our results in the light of literature data. We show that the mutation detection rates largely depend on the family history and clinical course of the disease. We present a list of 315 different point mutations and 37 large deletions detected in 634 of the 1166 index patients. Our results confirm previously published genotype-phenotype correlations with respect to the colorectal phenotype and extracolonic manifestations. However, 'exceptions to the rule' are also observed, and possible explanations for this are discussed. The discovery of autosomal-recessive <it>MUTYH</it>-associated polyposis (MAP) as a differential diagnosis to FAP implies that some results have to be reinterpreted and surveillance guidelines in the families have to be reevaluated.</p> http://www.hccpjournal.com/content/3/3/95familial adenomatous polyposis<it>APC </it>gene<it>APC </it>mutationsgenotype-phenotype correlations
collection DOAJ
language English
format Article
sources DOAJ
author Friedl Waltraut
Aretz Stefan
spellingShingle Friedl Waltraut
Aretz Stefan
Familial Adenomatous Polyposis: Experience from a Study of 1164 Unrelated German Polyposis Patients
Hereditary Cancer in Clinical Practice
familial adenomatous polyposis
<it>APC </it>gene
<it>APC </it>mutations
genotype-phenotype correlations
author_facet Friedl Waltraut
Aretz Stefan
author_sort Friedl Waltraut
title Familial Adenomatous Polyposis: Experience from a Study of 1164 Unrelated German Polyposis Patients
title_short Familial Adenomatous Polyposis: Experience from a Study of 1164 Unrelated German Polyposis Patients
title_full Familial Adenomatous Polyposis: Experience from a Study of 1164 Unrelated German Polyposis Patients
title_fullStr Familial Adenomatous Polyposis: Experience from a Study of 1164 Unrelated German Polyposis Patients
title_full_unstemmed Familial Adenomatous Polyposis: Experience from a Study of 1164 Unrelated German Polyposis Patients
title_sort familial adenomatous polyposis: experience from a study of 1164 unrelated german polyposis patients
publisher BMC
series Hereditary Cancer in Clinical Practice
issn 1897-4287
publishDate 2005-09-01
description <p>Abstract</p> <p>The autosomal-dominant precancerous condition familial adenomatous polyposis (FAP) is caused by germline mutations in the tumour suppressor gene <it>APC</it>. Consistent correlations between the site of mutations in the gene and clinical phenotype have been published for different patient groups. We report our experiences of <it>APC </it>mutation analysis and genotype-phenotype correlations in 1166 unrelated polyposis families and discuss our results in the light of literature data. We show that the mutation detection rates largely depend on the family history and clinical course of the disease. We present a list of 315 different point mutations and 37 large deletions detected in 634 of the 1166 index patients. Our results confirm previously published genotype-phenotype correlations with respect to the colorectal phenotype and extracolonic manifestations. However, 'exceptions to the rule' are also observed, and possible explanations for this are discussed. The discovery of autosomal-recessive <it>MUTYH</it>-associated polyposis (MAP) as a differential diagnosis to FAP implies that some results have to be reinterpreted and surveillance guidelines in the families have to be reevaluated.</p>
topic familial adenomatous polyposis
<it>APC </it>gene
<it>APC </it>mutations
genotype-phenotype correlations
url http://www.hccpjournal.com/content/3/3/95
work_keys_str_mv AT friedlwaltraut familialadenomatouspolyposisexperiencefromastudyof1164unrelatedgermanpolyposispatients
AT aretzstefan familialadenomatouspolyposisexperiencefromastudyof1164unrelatedgermanpolyposispatients
_version_ 1725364956230057984